Manufacturer
SANDOZ GMBH
Contents
Ampicillin Na
Indication
Supplement in systemic therapy for treatment of susceptible infections, Supplement in systemic therapy for treatment of susceptible infections, Supplement in systemic therapy for treatment of susceptible infections, Meningitis, Intrapartum prophylaxis against group B Streptoccocal infection in neonates, Susceptible infections, Septicaemia
Instruction
Administer via intra-articular,Intraperitoneal,Intrapleural,IV and Parenteral.
Drug interaction
May reduce the efficacy of OC. May alter INR while on warfarin and phenindione. May reduce the efficacy of oral typhoid vaccines. May reduce the excretion of methotrexate. Reduced excretion w/ probenecid and sulfinpyrazone, resulting to increased risk of toxicity. Allopurinol increases ampicillin-induced skin reactions. Reduced absorption w/ chloroquine. Bacteriostatic antibacterials (e.g. erythromycin, chloramphenicol, tetracycline) may interfere w/ the bactericidal action of ampicillin.
Malaysia
